Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion evidence source_evidence_literature NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion SIO_000772 15535838 NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion wasDerivedFrom befree-2016 NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_assertion wasGeneratedBy ECO_0000203 NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.
- befree-2016 importedOn "2016-02-19" NP468169.RASlS4E5UrbtqVddAxR84KLpo_eP2jyxzYjZKo3ku0D7A130_provenance.